Apimeds Pharmaceuticals US, Inc.

APUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 13, 2026 CURRENT REPORT
8-K Oct 1, 2026 CURRENT REPORT
8-K Sep 29, 2026 CURRENT REPORT
8-K Sep 23, 2026 CURRENT REPORT
8-K Sep 11, 2026 CURRENT REPORT
8-K Aug 21, 2026 CURRENT REPORT
10-Q Aug 14, 2026 QUARTERLY REPORT
8-K Aug 6, 2026 CURRENT REPORT
8-K Jul 13, 2026 CURRENT REPORT
10-Q May 26, 2026 QUARTERLY REPORT
NT 10-Q May 15, 2026 NOTIFICATION OF LATE FILING
SCHEDULE 13D/A May 7, 2026
8-K May 5, 2026 CURRENT REPORT
10-K May 4, 2026 ANNUAL REPORT
8-K May 4, 2026 CURRENT REPORT
8-K Apr 22, 2026 FORM 8-K
8-K Apr 16, 2026 CURRENT REPORT
425 Apr 9, 2026 AMENDMENT NO. 1 TO FORM 8-K
8-K/A Apr 9, 2026 AMENDMENT NO. 1 TO FORM 8-K
NT 10-K Mar 31, 2026 NOTIFICATION OF LATE FILING
SCHEDULE 13D/A Mar 30, 2026
8-K Mar 26, 2026 CURRENT REPORT
8-K Mar 25, 2026 CURRENT REPORT
SCHEDULE 13D/A Mar 20, 2026
8-K Mar 16, 2026 CURRENT REPORT
← Newer Page 1 of 6 · 127 filings Older →